• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与麦角酸二乙酰胺相关的抗精神病药恶性综合征中的肌肉表现。

The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.

作者信息

Behan W M, Bakheit A M, Behan P O, More I A

机构信息

University of Glasgow, Department of Pathology, UK.

出版信息

J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):741-3. doi: 10.1136/jnnp.54.8.741.

DOI:10.1136/jnnp.54.8.741
PMID:1940949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1014484/
Abstract

A detailed pathological description of the muscle findings in a case of the neuroleptic malignant syndrome (NMS) following ingestion of lysergic acid diethylamide (LSD) is given, including the first ultrastructural analysis. Focal necrosis, oedema, and hypercontraction of fibres with glycogen and lipid depletion, were identified, all of which had resolved completely a year later. The findings are compared with those in malignant hyperthermia. It is suggested that the results support the view that in NMS, the muscle rigidity is due to central mechanisms and, in both this disorder and malignant hyperthermia, it is responsible for the hyperpyrexia and its life-threatening complications.

摘要

本文给出了一例服用麦角酸二乙酰胺(LSD)后发生神经阻滞剂恶性综合征(NMS)患者肌肉检查结果的详细病理学描述,包括首次超微结构分析。发现有局灶性坏死、水肿以及纤维的过度收缩,并伴有糖原和脂质耗竭,所有这些在一年后已完全消退。将这些发现与恶性高热的发现进行了比较。结果表明支持以下观点:在NMS中,肌肉强直是由中枢机制引起的,并且在这种疾病和恶性高热中,它都是高热及其危及生命并发症的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/a54ddaca200e/jnnpsyc00506-0074-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/909dd5a1c368/jnnpsyc00506-0074-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/ac1adf9e2152/jnnpsyc00506-0074-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/a54ddaca200e/jnnpsyc00506-0074-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/909dd5a1c368/jnnpsyc00506-0074-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/ac1adf9e2152/jnnpsyc00506-0074-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b4/1014484/a54ddaca200e/jnnpsyc00506-0074-c.jpg

相似文献

1
The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.与麦角酸二乙酰胺相关的抗精神病药恶性综合征中的肌肉表现。
J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):741-3. doi: 10.1136/jnnp.54.8.741.
2
Muscle changes in the neuroleptic malignant syndrome.抗精神病药恶性综合征中的肌肉变化。
J Clin Pathol. 2000 Mar;53(3):223-7. doi: 10.1136/jcp.53.3.223.
3
A syndrome identical to the neuroleptic malignant syndrome induced by LSD and alcohol.一种与由麦角酸二乙酰胺(LSD)和酒精诱发的抗精神病药恶性综合征相同的综合征。
Br J Addict. 1990 Jan;85(1):150-1. doi: 10.1111/j.1360-0443.1990.tb00636.x.
4
Muscle pathology in the neuroleptic malignant syndrome.
J Neurol. 1987 Dec;235(2):120-1. doi: 10.1007/BF00718024.
5
Pathology of neuroleptic malignant syndrome.抗精神病药物恶性综合征的病理学
J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):271. doi: 10.1136/jnnp.53.3.271.
6
Neuroleptic malignant syndrome: caffeine contracture of single muscle fibers and muscle pathology.抗精神病药恶性综合征:单根肌纤维的咖啡因挛缩与肌肉病理学
Neurology. 1988 Feb;38(2):297-301. doi: 10.1212/wnl.38.2.297.
7
Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD).摄入麦角酸二乙酰胺(LSD)后出现持续性视觉残留。
Arch Ophthalmol. 1996 Jan;114(1):47-50. doi: 10.1001/archopht.1996.01100130045007.
8
Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology.抗精神病药恶性综合征:一例伴有尸检脑和肌肉病理学检查的病例报告
J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):1006-9. doi: 10.1136/jnnp.52.8.1006.
9
[Neuroleptic malignant syndrome and hydrocephalus in a patient with Huntington's chorea, accompanied by nemaline rods in biopsied muscle].[亨廷顿舞蹈症患者出现抗精神病药物恶性综合征和脑积水,活检肌肉中伴有杆状体肌病]
Rinsho Shinkeigaku. 1985 May;25(5):536-42.
10
Neuroleptic malignant syndrome in the intensive therapy unit.
Anaesthesia. 1990 Apr;45(4):311-3. doi: 10.1111/j.1365-2044.1990.tb14740.x.

引用本文的文献

1
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.作为精神病模型的麦角酸二乙酰胺(LSD):作用机制与药理学
Int J Mol Sci. 2016 Nov 23;17(11):1953. doi: 10.3390/ijms17111953.
2
Diagnostic evaluation of rhabdomyolysis.横纹肌溶解症的诊断评估。
Muscle Nerve. 2015 Jun;51(6):793-810. doi: 10.1002/mus.24606. Epub 2015 Mar 14.
3
Muscle changes in the neuroleptic malignant syndrome.抗精神病药恶性综合征中的肌肉变化。

本文引用的文献

1
Malignant hyperthermia.恶性高热
Anesthesiology. 1980 Nov;53(5):395-423. doi: 10.1097/00000542-198011000-00007.
2
Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
Neurology. 1983 Apr;33(4):516-8.
3
The neuroleptic syndrome and central dopamine metabolites.
J Clin Psychopharmacol. 1984 Jun;4(3):150-3.
4
J Clin Pathol. 2000 Mar;53(3):223-7. doi: 10.1136/jcp.53.3.223.
4
Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.5-羟色胺2A受体拮抗剂在氟烷诱导的猪恶性高热中缺乏预防或治疗效果。
Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):365-74. doi: 10.1007/BF00178953.
Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
抗精神病药恶性综合征。溴隐亭治疗成功。
JAMA. 1983 Jan 21;249(3):386-8.
5
Malignant hyperthermia in pigs: calcium ion uptake by mitochondria from skeletal muscle of susceptible animals given neuroleptic drugs and halothane.猪的恶性高热:给予抗精神病药物和氟烷后,易感动物骨骼肌线粒体对钙离子的摄取。
J Comp Pathol. 1982 Apr;92(2):191-8. doi: 10.1016/0021-9975(82)90077-9.
6
Dantrolene, a direct acting skeletal muscle relaxant.丹曲林,一种直接作用的骨骼肌松弛剂。
J Pharm Sci. 1973 Jun;62(6):948-51. doi: 10.1002/jps.2600620619.
7
Ultrastructural changes of muscle in malignant hyperthermia.恶性高热时肌肉的超微结构变化
J Neurol Sci. 1974 Jan;21(1):93-100. doi: 10.1016/0022-510x(74)90109-9.
8
Current concepts. Neuroleptic malignant syndrome.当前概念。抗精神病药物恶性综合征。
N Engl J Med. 1985 Jul 18;313(3):163-6. doi: 10.1056/NEJM198507183130306.
9
Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.
Anesthesiology. 1987 Jul;67(1):20-5. doi: 10.1097/00000542-198707000-00004.
10
Muscle pathology in the neuroleptic malignant syndrome.
J Neurol. 1987 Dec;235(2):120-1. doi: 10.1007/BF00718024.